Carnegie acted as joint global coordinator and joint bookrunner in the private placement of NOK 145 million in EXACT Therapeutics AS.
EXACT-Tx is a clinical-stage precision medicine company utilizing the power of ultrasound and microbubbles to enable targeted drug delivery in oncology.